Mission & Vision
Tollo Health pioneers the development of medical foods—nutritional therapies formulated under clinical guidance to manage conditions like long COVID, viral infections, muscle preservation, and inflammatory syndromes. The company’s core belief is that targeted nutrition can improve patient outcomes where standard diets fall short.
Flagship Product: Galectovid®
Proprietary Medical Food
Chewable tablets enriched with guar gum to inhibit Galectin‑1 and Galectin‑3—proteins implicated in viral persistence and immune dysregulation.
Clinical-Grade Standards
GRAS‑certified, USA‑manufactured, third‑party verified.
Physician-Supervised Use
Marketed for dietary management of viral and inflammatory conditions.
Market Opportunity
- Growing demand: Rising awareness around chronic viral/inflammatory conditions (e.g., long COVID, MCAS).
- Regulatory pathway clarity: Avoids drug development obstacles while delivering therapeutic benefits.
- Scalable model: Online subscription, tiered purchase discounts, telehealth partnerships.
Scientific & Clinical Foundation
Backed by formulation science and extraction techniques enhancing guar gum bioavailability.
Engages with the science of vaccine-related injuries and persistent viral infections.
Leadership & Track Record
Gerald Commissiong (CEO): Ex‑CEO and co‑founder of Amarantus Bioscience; led development of Alzheimer’s diagnostic and raised over $70 million in research funding.
Experienced management team blending life sciences, diagnostics, and market strategy.
Flagship Product: Galectovid®
Direct-to-Consumer Model
E-commerce powered by Shopify; global shipping.
Physician Network
Telehealth integration for safe, supervised access.
Consumer Incentives
Tiered discounts (buy‑2‑40%, buy‑4‑50%, buy‑6‑60%).
Why Invest?
| Advantages | Description |
|---|---|
| Innovative Therapy | Positioned at the intersection of nutrition and therapeutics. |
| Regulatory Efficiency | Medical food classification allows faster market entry than pharmaceuticals. |
| Leadership Credibility | Proven capital raiser with deep biotech and diagnostics experience. |
| Scalable Digital Infrastructure | E-commerce and telehealth readiness support growth. |
| Conditions Tailored | Focus on long COVID, viral persistence, MCAS, and muscle health—all emerging needs. |